注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Chemomab Therapeutics Ltd(原名:Anchiano Therapeutics Ltd)是一家以色列的生物製藥公司。該公司專門從事患者靶向療法的開發業務,用於治療多種癌症。其治療和診斷技術BC-819構成了靶向破壞癌細胞的搜索範式,對癌細胞的周圍組織沒有影響,也沒有觀察到的副作用,可以長期、安全地治療和預防癌症。其患者靶向療法基於識別僅在腫瘤中表達的特定基因。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Neil Harris Cohen | 58 | 2020 | Independent Director |
Alan Charles Moses | 74 | 2021 | Independent Director |
Arun J. Sanyal | - | - | Member of Scientific Advisory Board |
Nissim Darvish | 59 | 2021 | Independent Chairman |
Massimo Pinzani | - | - | Member of Scientific Advisory Board |
Claude Nicaise | 70 | 2021 | Independent Director |
Adi Mor George | 41 | 2011 | Co-Founder, Chief Scientific Officer, CEO & Executive Director |
Scott L. Friedman | - | - | Member of Scientific Advisory Board |
Jill M. Quigley | 47 | 2022 | Independent Director |
Jacob George | - | - | Member of Scientific Advisory Board |
Dinesh Khanna | - | - | Member of Scientific Advisory Board |
Francesco Del Galdo | - | - | Member of Scientific Advisory Board |
Marco Matucci-Cerinic | - | - | Member of Scientific Advisory Board |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核